An informative and comprehensive review from the leading researchers in the field, this book provides a complete one-stop guide to neuroimaging techniques and their application to a wide range of neuropsychiatric disorders. For each disorder or group of disorders, separate chapters review the most up-to-date findings from structural imaging, functional imaging and/or molecular imaging. Each section ends with an overview from a internationally-renowned luminary in the field, addressing the question of ‘What do we know and where are we going?' Richly illustrated throughout, each chapter includes a ‘summary box', providing readers with explicit take-home messages. This is an essential resource for clinicians, researchers and trainees who want to learn how neuroimaging tools lead to new discoveries about brain and behaviour associations in neuropsychiatric disorders.
Ashtari M , Cottone J , Ardekani B , et al. 2007. Disruption of white matter integrity in the inferior longitudinal fasciculus in adolescents with schizophrenia as revealed by fiber tractography. Arch Gen Psychiatry 64, 1270–80.
Ellison-Wright I , Glahn D , Laird A , Thelen S and Bullmore E. 2008. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165, 1015–23.
Foong J , Maier M , Clark C A , Barker G J , Miller D H and Ron M A. 2000. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 68, 242–4.
Fujiwara H , Namiki C , Hirao K , et al. 2007. Anterior and posterior cingulum abnormalities and their association with psychopathology in schizophrenia: a diffusion tensor imaging study. Schizophr Res 95, 215–22.
Glahn D , Laird A , Ellison-Wright I , et al. 2008. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64, 774–81.
Gur R E , Cowell P , Turetsky B I , et al. 1998. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 55, 145–52.
Jones D K , Catani M , Pierpaoli C , et al. 2006. Age effects on diffusion tensor magnetic resonance imaging tractography measures of frontal cortex connections in schizophrenia. Hum Brain Mapp 27, 230–8.
Karlsgodt K , van Erp T , Poldrack R , Bearden C , Nuechterlein K and Cannon T. 2008. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry 63, 512–8.
Kasai K , Shenton M E , Salisbury D F , et al. 2003. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 60, 766–75.
Lawrie S M , Buechel C , Whalley H C , Frith C D , Friston K J and Johnstone E C. 2002. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biological Psychiatry 51, 1008–11.
Lim K O , Hedehus M , Moseley M , de Crespigny A , Sullivan E V and Pfefferbaum A. 1999. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56, 367–74.
Manoach D , Ketwaroo G , Polli F , et al. 2007. Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia. Neuroimage 37, 599–610.
Mitelman S , Torosjan Y , Newmark R , et al. 2007. Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey. Schizophr Res 92, 211–24.
Pfefferbaum A , Mathalon D H , Sullivan E V , Rawles J M , Zipursky R B and Lim K O . 1994. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51, 874–87.
Roy K , Murtie J , El-Khodor B , et al. 2007. Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 104, 8131–6.
Salisbury D , Kuroki N , Kasai K , Shenton M and McCarley R. 2007. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 64, 521–9.
Seok J , Park H , Chun J , et al. 2007. White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Psychiatry Res 156, 93–104.
Song S , Sun S , Ju W , Lin S , Cross A and Neufeld A. 2003. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20, 1714–22.
Steen R , Mull C , McClure R , Hamer R and Lieberman J. 2006. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188, 510–8.
van Haren N , Hulshoff Pol H , Schnack H , et al. 2008. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry 63, 106–13.
White T , Kendi A , Lehéricy S , et al. 2007. Disruption of hippocampal connectivity in children and adolescents with schizophrenia – a voxel-based diffusion tensor imaging study. Schizophr Res 90, 302–7.
Whitford T J , Grieve S M , Farrow T F , et al. 2006. Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. NeuroImage 32, 511–9.
Whitford T J , Grieve S M , Farrow T F , et al. 2007a. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry 164, 1082–9.
Whitford T J , Rennie C J , Grieve S M , Clark C R , Gordon E and Williams L M. 2007b. Brain maturation in adolescence: concurrent changes in neuroanatomy and neurophysiology. Human Brain Mapp 28, 228–37.
Wolkin A , Choi S , Szilagyi S , Sanfilipo M , Rotrosen J and Lim K. 2003. Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study. Am J Psychiatry 160, 572–4.
Wood S , Pantelis C , Velakoulis D , Yücel M , Fornito A and McGorry P. 2008. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull 34, 322–9.
Arfanakis K , Cordes D , Haughton V M , et al. 2000. Combining independent component analysis and correlation analysis to probe interregional connectivity in fMRI task activation datasets. Magn Reson Imaging 18, 921–30.
Calhoun V D , Adali T , Giuliani N R , et al. 2006a. Method for multimodal analysis of independent source differences in schizophrenia: combining gray matter structural and auditory oddball functional data. Hum Brain Mapp 27, 47–62.
Callicott J H , Egan M F , Mattay V S , et al. 2003a. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160, 709–19.
Callicott J H , Ramsey N F , Tallent K , et al. 1998. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 18, 186–96.
Cohen J D , Braver T S , O'Reilly R C , et al. 1996. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges. Phil Trans R Soc Lond B Biol Sci 351, 1515–27.
De Luca M , Smith S , De Stefano N , et al. 2005. Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res 167, 587–94.
Demirci O , Stevens M C , Andresen N C , et al. 2009. Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls. Neuroimage 46, 419–31.
Di Giorgio A , Blasi G , Sambataro F , et al. 2008. Association of the SerCys DISC1 polymorphism with human hippocampal formation gray matter and function during memory encoding. Eur J Neurosci 28, 2129–36.
Driesen N R , Leung H C , Calhoun V D , et al. 2008. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry 64, 1026–34.
Ford J M , Gray M , Whitfield S L , et al. 2004. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 61, 119–29.
Friedman H R and Goldman-Rakic P S . 1994. Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J Neurosci 14, 2775–88.
Greicius M D , Srivastava G , Reiss A L , et al. 2004. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101, 4637–42.
Holt D J , Kunkel L , Weiss A P , et al. 2006. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr Res 82, 153–62.
Kiehl K A , Stevens M C , Laurens K R , et al. 2005. An adaptive reflexive processing model of neurocognitive function: supporting evidence from a large scale (n = 100) fMRI study of an auditory oddball task. Neuroimage 25, 899–915.
Manoach D S , Gollub R L , Benson E S , et al. 2000. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 48, 99–109.
Manoach D S , Greve D N , Lindgren K A , et al. 2003. Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI. Neuroimage 20, 1670–84.
Minzenberg M J , Laird A R , Thelen S , et al. 2009. Meta-analysis of 41 functional neuroimaging studies of executive function reveals dysfunction in a general-purpose cognitive control system in schizophrenia. Arch Gen Psychiatry 66, 811–22.
Petrides M. 1995. Impairments on nonspatial self-ordered and externally ordered working memory tasks after lesions of the mid-dorsal part of the lateral frontal cortex in the monkey. J Neurosci 15, 359–75.
Surguladze S , Russell T , Kucharska-Pietura K , et al. 2006. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol Psychiatry 60, 423–31.
Wible C G , Lee K , Molina I , et al. 2009. fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull 35, 47–57.
Chang L , Friedman J , Ernst T , Zhong K , Tsopelas N D and Davis K. 2007. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 62, 1396–404.
de Kruijff B , Verkley A J , van Echteld C J , et al. 1979. The occurrence of lipidic particles in lipid bilayers as seen by 31P NMR and freeze–fracture electron-microscopy. Biochim Biophys Acta 555, 200–09.
Delamillieure P , Constans J M , Fernandez J , Brazo P and Dollfus S. 2004. Relationship between performance on the Stroop test and N-acetylaspartate in the medial prefrontal cortex in deficit and nondeficit schizophrenia: preliminary results. Psychiatry Res 132, 87–9.
Fukuzako H , Fukuzako T , Hashiguchi T , Kodama S , Takigawa M and Fujimoto T. 1999. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am J Psychiatry 156, 1205–08.
Fukuzako H , Fukuzako T , Takeuchi K , et al. 1996. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 20, 629–40.
Gangadhar B N , Jayakumar P N , Venkatasubramanian G , Janakiramaiah N and Keshavan M S. 2006. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 30, 910–3.
Gonen O , Gruber S , Li B S , Mlynarik V and Moser E. 2001. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. Am J Neuroradiol 22, 1727–31.
Gonzalez-Mendez R , Litt L , Koretsky A P , von Colditz J , Weiner M W and James T L. 1984. Comparison of 31P NMR spectra of in vivo rat brain using convolution difference and saturation with a surface coil. Source of the broad component in the brain spectrum. J Magn Reson 57, 526–33.
Jakary A , Vinogradov S , Feiwell R and Deicken R F. 2005. N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI. Schizophr Res 76, 173–85.
Jayakumar P N , Gangadhar B N , Subbakrishna D K , Janakiramaiah N , Srinivas J S and Keshavan M S. 2003. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia: a 31P magnetic resonance spectroscopy study. Biol Psychiatry 54, 491–4.
Jayakumar P N , Venkatasubramanian G , Keshavan M S , Srinivas J S and Gangadhar B N. 2006. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naive schizophrenia. Acta Psychiatr Scand 114, 346–51.
Jensen J E , Al Semaan Y M , Williamson P C , et al. 2002a. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia: (31)P-MRS study at 4.0 Tesla. Br J Psychiatry 180, 39–44.
Jensen J E , Miller J , Williamson P C , et al. 2004. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry 184, 409–15.
Jensen J E , Miller J , Williamson P C , et al. 2006. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla. Psychiatry Res 146, 127–35.
Kennedy C and Sokoloff L. 1957. An adaptation of the nitrous oxide method to the study of the cerebral circulation in children; normal values for cerebral blood flow and cerebral metabolic rate in childhood. J Clin Invest 36, 1130–7.
Keshavan M S , Pettegrew J W , Panchalingam K S , Kaplan D and Bozik E. 1991. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Arch Gen Psychiatry 48, 1112–3.
Keshavan M S , Stanley J A , Montrose D M , Minshew N J and Pettegrew J W. 2003. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo31P MRS study. Mol Psychiatry 8, 316–23.
Li C W , Negendank W G , Murphy-Boesch J , Padavic-Shaller K and Brown T R. 1996. Molar quantitation of hepatic metabolites in vivo in proton-decoupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9, 141–55.
McClure R J , Keshavan M S and Pettegrew J W. 1998. Chemical and physiologic brain imaging in schizophrenia. In Buckley P F (Ed.) The Psychiatric Clinics of North America Schizophrenia, Philadelphia: W.B. Saunders, pp. 93–122.
Merrill A H J and Sandhoff K. 2002. Sphingolipids: metabolism and cell signaling. In Vance D E and Vance J E (Eds) Biochemistry of Lipids, Lipoproteins and Membranes. New York, NY: Elsevier, pp. 390–407.
Miyaoka T , Yasukawa R , Mizuno S , et al. 2005. Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J Psychiatr Res 39, 29–34.
Molina V , Sanchez J , Sanz J , et al. 2007. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry J Assoc Eur Psychiatrists 22, 505–12.
Murphy E J , Bates T E , Williams S R , et al. 1992. Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths. Biochim Biophys Acta 1111, 51–8.
Ohrmann P , Siegmund A , Suslow T , et al. 2007. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J Psychiatr Res 41, 625–34.
Ohrmann P , Siegmund A , Suslow T , et al. 2005. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 73, 153–7.
Pettegrew J W , Keshavan M S , Panchalingam K , et al. 1991. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry 48, 563–8.
Pettegrew J W , Panchalingam K , Withers G , McKeag D and Strychor S. 1990. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J Neuropathol Exp Neurol 49, 237–49.
Purdon S E , Valiakalayil A , Hanstock C C , Seres P and Tibbo P. 2008. Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia. Schizophr Res 99, 218–24.
Puri B K , Counsell S J , Hamilton G , et al. 2004. Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study. Prostag Leukotri and Ess Fatty Acids 70, 409–11.
Puri B K , Counsell S J , Hamilton G , Bustos M and Treasaden I H. 2008. Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended. Prog Neuropsychopharmacol Biol Psychiatry 32, 751–4.
Riehemann S , Hubner G , Smesny S , Volz H P and Sauer H. 2002. Do neuroleptics alter the cerebral intracellular pH value in schizophrenics? A (31)P-MRS study on three different patient groups. Psychiatry Res 114, 113–7.
Rothermundt M , Ohrmann P , Abel S , et al. 2007. Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol. Prog Neuropsychopharmacol Biol Psychiatry 31, 361–4.
Shedd S F , Lutz N W and Hull W E. 1993. The influence of medium formulation on phosphomonoester and UDP-hexose levels in cultured human colon tumor cells as observed by 31P NMR spectroscopy. NMR Biomed 6, 254–63.
Shirayama Y , Yano T , Takahashi K , Takahashi S and Ogino T. 2004. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. Eur J Neurosci 20, 749–56.
Stanley J A and Pettegrew J W. 2001. Post-processing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo 31-P brain spectra. Magn Reson Med 45, 390–6.
Stanley J A , Vemulapalli M , Nutche J , et al. 2007. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study. Schizophr Res 93, 23–32.
Steen R G , Hamer R M and Lieberman J A. 2005. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Crit Rev Neurobiol 30, 1949–62.
Szulc A , Galinska B , Tarasow E , et al. 2005. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS). Pharmacopsychiatry 38, 214–9.
Tanaka Y , Obata T , Sassa T , et al. 2006. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry and Clin Neurosci 60, 365–72.
Tang C Y , Friedman J , Shungu D , et al. 2007. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry 7, 25.
Terpstra M , Vaughan T J , Ugurbil K , Lim K O , Schulz S C and Gruetter R. 2005. Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia. Magma 18, 276–82.
Theberge J , Al Semaan Y , Drost D J , et al. 2004a. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res 131, 107–14.
Van Elst L T , Valerius G , Buchert M , et al. 2005. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry 58, 724–30.
Vance D E. 1991. Phospholipid metabolism and cell signalling in eucaryotes. In Vance D E and Vance J E (Eds) Biochemistry of Lipids, Lipoproteins and Membranes, Volume 20. New York, NY: Elsevier, pp. 205–40.
Volz H R , Riehemann S , Maurer I , et al. 2000. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47, 954–61.
Weickert C S and Kleinman J E. 1998. The neuroanatomy and neurochemistry of schizophrenia. In Buckley P F (Ed.) The Psychiatric Clinics of North America Schizophrenia. Philadelphia: W.B. Saunders, pp. 57–75.
Wood S J , Berger G E , Lambert M , et al. 2006. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 63, 969–76.
Wood S J , Yucel M , Wellard R M , et al. 2007. Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. Schizophr Res 94, 328–31.
Abi-Dargham A , Kegeles L S , Zea-Ponce Y , et al. 2004. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry 55, 1001–06.
Breier A , Su T P , Saunders R , et al. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A 94, 2569–74.
Erritzoe D , Rasmussen H , Kristiansen K , et al. 2006. Serotonin 2A binding in neuroleptics-naïve schizophrenic patients and healthy controls using PET and [18-F]altanserin. NeuroImage 31, T44–186 [Abstract].
Erritzoe D , Rasmussen H , Kristiansen K T , et al. 2008. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients. Neuropsychopharmacology 33, 2435–41.
Farde L , Wiesel F A , Stone-Elander S , et al. 1990. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry 47, 213–9.
Frankle W G , Narendran R , Huang Y , et al. 2005. Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB. Biol Psychiatry 57, 1510–6.
Joyce J N , Shane A , Lexow N , Winokur A , Casanova M F and Kleinman J E. 1993. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315–36.
Krystal J H , Abi-Saab W , Perry E , et al. 2005. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 179, 303–9.
Laruelle M , Abi-Dargham A , Casanova M F , Toti R , Weinberger D R and Kleinman J E. 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: a postmortem study. Arch Gen Psychiatry 50, 810–8.
Laruelle M , Abi-Dargham A , van Dyck C H , Gil R and D'Souza C D. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93, 9235–40.
Martinez D , Gelernter J , Abi-Dargham A , et al. 2001. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24, 553–60.
Mukherjee J , Christian B T , Dunigan K A , et al. 2002. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies and preliminary assessment of sensitivity to aging effects on dopamine D2/D3 receptors. Synapse, 46, 170–88.
Mukherjee J , Christian B T , Narayanan T K , Shi B and Collins D. 2005. Measurement of d-amphetamine-induced effects on the binding of dopamine D2/D3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non human primates using PET. Brain Res 1032, 77–84.
Mukherjee J , Christain B T , Narayanan T K , Shi B and Mantil J. 2001. Evaluation of dopamine D2 receptor occupancy by clozapine, risperidone and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology, 25, 476–88.
Mukherjee J , Shi B , Christian B T , Chattopadhyay S , and Narayanan T K . 2004. 11C-fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. Bioorg Med Chem 12, 95–102.
Nyberg S , Olsson H , Nilsson U , Maehlum E , Halldin C and and Farde L. 2002. Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole. Psychopharmacology (Berl) 162, 37–41.
Wong D F , Potter W Z and Brašić J R. 2002. Proof of concept: functional models for drug development in humans. In Davis K L , Charney D , Coyle J T and Nemeroff C (Eds) Neuropsychopharmacology: The Fifth Generation of Progress. Baltimore, MD: Lippincott Williams and Wilkins, pp. 457–73.
Wong D F , Gjedde A , Wagner H N, Jr , et al. 1986. Quantification of neuroreceptors in the living human brain. II. inhibition studies of receptor density and affinity. J Cerebr Blood Flow Metab 6, 147–53.
Wong D F , Kuwabara H , Schretlen D J , et al. 2006. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 31, 2716–27. Erratum in: Neuropsychopharmacology 2007; 32, 256.
Wong D F , Brašić J R , Singer H S , et al. 2008. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette Syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33, 1239–51.
Yokoi F , Gründer G , Biziere K , et al. 2002. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Neuropsychopharmacology 27, 248–59.
Zanardi R , Artigas F , Moresco R , et al. 2001. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 21, 53–8.
Andreasen N C , Cohen G C , Harris G , Parkkinen J , Rezai K and Swayze V W. 1992. Image processing for the study of brain structure and function: Problems and programs. Journal of Neuropsychiatry and Clinical Neuroscience 4, 125–33.
Arndt S , Cizadlo T , Andreasen N C , Heckel D , Gold S and O'Leary D . 1996. Tests for comparing images based on randomization and permutation methods. Journal of Cerebral Blood Flow and Metabolism 16, 1271–9.
Dorph-Petersen K A , Pierri J N , Perel J M , Sun Z , Sampson A R , and Lewis D A . 2005. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649–61.
Miller D D , Andreasen N C , O'Leary D S , Watkins G L , Boles Ponto L L and Hichwa R D . 2001. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biological Psychiatry 49, 704–15.
Shenton M E , Kikinis R , Jolesz F A , et al. 1992. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. New England Journal of Medicine 327, 604–12.
Sowell E R , Thompson P M , Tessner K D and Toga A W. 2001. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: Inverse relationships during postadolescent brain maturation. Journal of Neuroscience 21, 8819–29.
Whitford T J , Grieve S M , Farrow T F , et al. 2006. Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: A tensor-based morphometry study. Neuroimage 32, 511–9.
Adler C M , Adams J , DelBello M P , et al. 2006b. Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: A diffusion tensor imaging study. Am J Psychiatry 163, 322–4.
Altshuler L L , Bartzokis G , Grieder T , Curran J and Mintz J . 1998. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: An MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry 55, 663–4.
Blumberg H P , Krystal J H , Bansal R , et al. 2006. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: A cross-sectional study. BiolPsychiatry 59, 611–8.
Bonelli R M , Kapfhammer H P , Pillay S S and Yurgelun-Todd D A . 2006. Basal ganglia volumetric studies in affective disorder: What did we learn in the last 15 years? J Neural Transmission 113, 255–68.
Chepenik L G , Fredericks C , Papademetris X , et al. 2009. Effects of the brain-derived neurotrophic growth factor Val66Met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 34, 944–51.
DelBello M P , Zimmerman M E , Mills N P , Getz G E and Strakowski S M . 2004. Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disord 6, 43–52.
Farrow T F , Whitford T J , Williams L M , Gomes L and Harris A W . 2005. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry 58, 713–23.
Frangou S , Hadjulis M , Chitnis X , Baster D , Donaldson S and Raymont V . 2002. The Maudsley Bipolar Disorder Project: Brain structural changes in bipolar I disorder. Bipolar Disor 4(Suppl 1), 123–4.
Haznedar M M , Roversi F , Pallanti S , et al. 2005. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry 57, 733–42.
Houenou J , Wessa M , Douaud G , et al. 2007. Increased white matter connectivity in euthymic bipolar patients: Diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry 12, 1001–10.
Kempton M J , Gedes J R , Ettinger U , Williams S C R and Grasby P M . 2008. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 65, 1017–32.
Konarski J Z , McIntyre R S , Kennedy S H , Rafi-Tari S , Soczynska J K and Ketter T A . 2008. Volumetric neuroimaging investigations in mood disorder: Bipolar disorder versus major depressive disorder. Bipolar Disord 10, 1–37.
Koo M S , Levitt J J , Salisbury D F , Nakamura M , Shenton M E and McCarley R W . 2008. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 65, 746–60.
Kraepelin E . 1921. Manic-Depressive Insanity and Paranoia (transl. R M Barclay ), G M Robertson , Ed. Edinburgh: E . and S. Livingstone ; reproduced in the series “The Classic of Psychiatry and Behavioral Sciences Library”, E T Carlson , Ed. Birmingham, AL: Gryphon Editions, Inc., p. 138.
Lochhead R A , Parsey R V , Oquendo M A and Mann J J . 2004. Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry. Biol Psychiatry 55, 1154–62.
Narrow W E , Rae D S , Robins L N and Regier D A . 2002. Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 59, 115–23.
Pfeiffer J C , Welge J , Strakowski S M , Adler C M and DelBello M P . 2008. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 47, 1290–9.
Roy-Byrne P P , Post R M , Uhde T W , Porcu T and Davis D . 1985. The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 71 (suppl 317), 1–34.
Sharma V , Menon R , Carr T J , Densmore M , Mazmanian D and Williamson P C . 2003. An MRI study of subgenual prefrontal cortex in patients with familial and non-familial bipolar I disorder. J Affect Disord 77, 167–71.
Strakowski S M. 2002. Differential brain mechanisms in bipolar and unipolar disorders: Considerations from brain imaging. In Soares J C (Ed) Brain Imaging in Affective Disorders. New York, NY: Marcel Dekker, Inc.
Strakowski S M , Adler C M , Holland S K , Mills N P and DelBello M P . 2004. A preliminary fMRI study of sustained attention in unmedicated, euthymic bipolar disorder. Neuropsychopharmacology 29, 1734–40.
Strakowski S M , Adler C M and DelBello M P . 2007. Metabolic dysfunction within the anterior limbic network in bipolar disorder: A model for studying new treatments. Neuropsychiatria i Neuropsychologia (Neuropsychiatry and Neuropsychology; Poland) 1, 5–14.
Versace A , Almeida J R , Hassel S , et al. 2008. Elevated left and reducted right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry 65, 1041–52.
Adler C M , Delbello M P , Mills N P , Schmithorst V , Holland S and Strakowski S M . 2005. Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task. Bipolar Disord 7, 577–88.
Adler C M , Holland S K , Schmithorst V , Tuchfarber M J and Strakowski S M . 2004. Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disord 6, 540–9.
Benedetti F , Bernasconi A , Blasi V , et al. 2007. Neural and genetic correlates of antidepressant response to sleep deprivation: A functional magnetic resonance imaging study of moral valence decision in bipolar depression. Arch Gen Psychiatry 64, 179–87.
Blumberg H P , Leung H C , Skudlarski P , et al. 2003a. A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60, 601–09.
Caligiuri M P , Brown G G , Meloy M J , et al. 2003. An fMRI study of affective state and medication on cortical and subcortical brain regions during motor performance in bipolar disorder. Psychiatry Res 123, 171–82.
Chang K , Adleman N E , Dienes K , Simeonova D I , Menon V and Reiss A . 2004. Anomalous prefrontal–subcortical activation in familial pediatric bipolar disorder: A functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61, 781–92.
Chang K D , Wagner C , Garrett A , Howe M and Reiss A . 2008. A preliminary functional magnetic resonance imaging study of prefrontal–amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine. Bipolar Disord 10, 426–31.
Chen C H , Lennox B , Jacob R , et al. 2006. Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: A functional magnetic resonance imaging study. Biol Psychiatry 59, 31–9.
Drapier D , Surguladze S , Marshall N , et al. 2008. Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biol Psychiatry 64, 513–20.
Drevets W C , Price J L , Bardgett M E , Reich T , Todd R D and Raichle M E . 2002. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 71, 431–47.
Dunn R T , Kimbrell T A , Ketter T A , et al. 2002. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol Psychiatry 51, 387–99.
Dye S M , Spence S A , Bench C J , et al. 1999. No evidence for left superior temporal dysfunction in asymptomatic schizophrenia and bipolar disorder. PET study of verbal fluency. Br J Psychiatry 175, 367–74.
Elliott R , Ogilvie A , Rubinsztein J S , Calderon G , Dolan R J and Sahakian B J . 2004. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiatry 55, 1163–70.
Foland L C , Altshuler L L , Bookheimer S Y , Eisenberger N , Townsend J and Thompson P M . 2008. Evidence for deficient modulation of amygdala response by prefrontal cortex in bipolar mania. Psychiatry Res 162, 27–37.
Frangou S , Kington J , Raymont V and Shergill S S . 2008. Examining ventral and dorsal prefrontal function in bipolar disorder: A functional magnetic resonance imaging study. Eur Psychiatry 23, 300–08.
Goodwin G M , Cavanagh J T , Glabus M F , Kehoe R F , O'Carroll R E and Ebmeier K P . 1997. Uptake of 99mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: Associations with mania. Br J Psychiatry 170, 426–30.
Gyulai L , Alavi A , Broich K , Reilley J , Ball W B and Whybrow P C . 1997. I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study. Biol Psychiatry 41, 152–61.
Haldane M , Jogia J , Cobb A , Kozuch E , Kumari V and Frangou S . 2008. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol 18, 48–54.
Jogia J , Haldane, M. , Cobb, A. , Kumari, V. and Frangou S . 2008. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry 192, 197–201.
Lawrence N S , Williams A M , Surguladze S , et al. 2004. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55, 578–87.
Liotti M , Mayberg H S , Brannan S K , Mcginnis S , Jerabek P and Fox P T . 2000. Differential limbic–cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiatry 48, 30–42.
Malhi G S , Lagopoulos J , Owen A M , Ivanovski B , Shnier R and Sachdev P . 2007a. Reduced activation to implicit affect induction in euthymic bipolar patients: an fMRI study. J Affect Disord 97, 109–22.
Malhi G S , Lagopoulos J , Sachdev P S , Ivanovski B , Shnier R and Ketter T . 2007b. Is a lack of disgust something to fear? A functional magnetic resonance imaging facial emotion recognition study in euthymic bipolar disorder patients. Bipolar Disord 9, 345–57.
Marchand W R , Lee J N , Thatcher G W , et al. 2007a. A functional MRI study of a paced motor activation task to evaluate frontal–subcortical circuit function in bipolar depression. Psychiatry Res 155, 221–30.
Marchand W R , Lee J N , Thatcher J , Thatcher G W , Jensen C and Starr J . 2007b. A preliminary longitudinal fMRI study of frontal–subcortical circuits in bipolar disorder using a paced motor activation paradigm. J Affect Disord 103, 237–41.
Matsuo K , Kouno T , Hatch J P , et al. 2007. A near-infrared spectroscopy study of prefrontal cortex activation during a verbal fluency task and carbon dioxide inhalation in individuals with bipolar disorder. Bipolar Disord 9, 876–83.
Pavuluri M N , O'Connor M M , Harral E M and Sweeney J A . 2008. An fMRI study of the interface between affective and cognitive neural circuitry in pediatric bipolar disorder. Psychiatry Res 162, 244–55.
Silverstone P H , Bell E C , Willson M C , Dave S and Wilman A H . 2005. Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: An fMRI study. Ann Gen Psychiatry 4, 14.
Stern C E , Owen A M , Tracey I , Look R B , Rosen B R and Petrides M . 2000. Activity in ventrolateral and mid-dorsolateral prefrontal cortex during nonspatial visual working memory processing: Evidence from functional magnetic resonance imaging. Neuroimage 11, 392–9.
Strakowski S M , Adler C M , Holland S K , Mills N and Delbello M P . 2004. A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology 29, 1734–40.
Strakowski S M , Adler C M , Holland S K , Mills N P , Delbello M P and Eliassen J C . 2005. Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. Am J Psychiatry 162, 1697–705.
Benes F M , Todtenkopf M S , Logiotatos P and Williams M . 2000. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J Chem Neuroanat 20, 259–69.
Bertolino A , Frye M , Callicott J H , et al. 2003. Neuronal pathology in the hippocampal area of patients with bipolar disorder: A study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53, 906–13.
Blasi G , Bertolino A , Brudaglio F , et al. 2004. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: A proton magnetic resonance spectroscopic imaging study. Psychiatry Res 131, 95–105.
Brooks J O , Wang P W , Bonner J C , et al. 2009b. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder. J Psychiatr Res 43, 181–8.
Cecil K M , DelBello M P , Sellars M C and Strakowski S M . 2003. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders. J Child Adolesc Psychopharmacol 13, 545–55.
Davanzo P , Thomas M A , Yue K , et al. 2001. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24, 359–69.
Dean B , Pavey G , McLeod M , Opeskin K , Keks N and Copolov D . 2001. A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder. J Affect Disord 66, 147–58.
Ebert D , Feistel H , Kaschka W , Barocka A and Pirner A . 1994. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation – Preliminary results. Biol Psychiatry 35, 880–5.
Frey B N , Stanley J A , Nery F G , et al. 2007b. Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: An in vivo 1H MRS study. Bipolar Disord 9 Suppl 1, 119–27.
Frye M A , Thomas M A , Yue K , et al. 2007a. Reduced concentrations of N-acetylaspartate (NAA) and the NAA–creatine ratio in the basal ganglia in bipolar disorder: A study using 3-Tesla proton magnetic resonance spectroscopy. Psychiatry Res 154, 259–65.
Gyulai L , Bolinger L , Leigh J S , Barlow C and Chance B . 1984. Phosphorylethanolamine – The major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain. FEBS Lett 178, 137–42.
Hajek T , Bernier D , Slaney C , et al. 2008. A comparison of affected and unaffected relatives of patients with bipolar disorder using proton magnetic resonance spectroscopy. J Psychiatry Neurosci 33, 531–40.
Hamakawa H , Kato T , Murashita J and Kato N . 1998. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci 248, 53–8.
Hamakawa H , Kato T , Shioiri T , Inubushi T and Kato N . 1999. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 29, 639–44.
Kato T , Hamakawa H , Shioiri T , et al. 1996. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 21, 248–54.
Kato T , Murashita J , Kamiya A , Shioiri T , Kato N and Inubushi T . 1998. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: A confirmation in drug-free patients and correlation with white matter hyperintensity. Eur Arch Psychiatry Clin Neurosci 248, 301–6.
Kato T , Shioiri T , Murashita J , Hamakawa H , Inubushi T and Takahashi S . 1994a. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res 55, 41–50.
Kato T , Shioiri T , Murashita J , et al. 1995. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 25, 557–66.
Kato T , Takahashi S , Shioiri T and Inubushi T . 1993. Alterations in brain phosphorus metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 27, 53–9.
Kato T , Takahashi S , Shioiri T , Murashita J , Hamakawa H and Inubushi T . 1994b. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31, 125–33.
Malhi G S , Ivanovski B , Wen W , Lagopoulos J , Moss K and Sachdev P . 2007. Measuring mania metabolites: A longitudinal proton spectroscopy study of hypomania. Acta Psychiatr Scand 434(Suppl), 57–66.
Marazziti D , Lenzi A , Raffaelli S , Falcone M F , Aglietti M and Cassano G B . 1993. A single electroconvulsive treatment affects platelet serotonin uptake in bipolar I patients. Eur Neuropsychopharmacol 3, 33–6.
Molina V , Sánchez J , Sanz J , et al. 2007. Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry 22, 505–12.
Moore C M , Breeze J L , Gruber S A , et al. 2000a. Choline, myo-inositol and mood in bipolar disorder: A proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2, 207–16.
Moore G J , Bebchuk J M , Parrish J K , et al. 1999. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156, 1902–08.
Ng W X , Lau I Y , Graham S and Sim K. 2009. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: A review and synthesis. Neurosci Biobehav Rev 33, 336–54.
Nudmamud S , Reynolds L M and Reynolds G P . 2003. N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: A postmortem study. Biol Psychiatry 53, 1138–41.
Olvera R L , Caetano S C , Fonseca M , et al. 2007. Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients. J Child Adolesc Psychopharmacol 17, 461–73.
Port J D , Unal S S , Mrazek D A and Marcus S M . 2008. Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Res 162, 113–21.
Silverstone P H , Hanstock C C , Fabian J , Staab R and Allen P S . 1996. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS. Biol Psychiatry 40, 235–46.
Silverstone P H , Hanstock C C and Rotzinger S . 1999. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy. J Psychiatry Neurosci 24, 222–6.
Silverstone P H , Wu R H , O'Donnell T , Ulrich M , Asghar S J and Hanstock C C . 2002. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients. Hum Psychopharmacol 17, 321–7.
Stahl S M , Woo D J , Mefford I N , Berger P A and Ciaranello R D . 1983. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am J Psychiatry 140, 26–30.
Wang P W , Sailasuta N , Chandler R A and Ketter T A . 2006. Magnetic resonance spectroscopic measurement of cerebral gamma-aminobutyric acid concentrations in patients with bipolar disorders. Acta Neuropsychiatrica 18, 120–6.
Wu R H , O'Donnell T , Ulrich M , Asghar S J , Hanstock C C and Silverstone P H . 2004. Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate. Ann Gen Hosp Psychiatry 3, 13.
Zubieta J K , Huguelet P , Ohl L E , et al. 2000. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: Sex differences and cognitive correlates. Am J Psychiatry 157, 1619–28.
Zubieta J K , Taylor S F , Huguelet P , Koeppe R A , Kilbourn M R and Frey K A . 2001. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 49, 110–6.
Alexopoulos G S , Kiosses D N , Choi S J , Murphy C F and Lim K O . 2002. Frontal white matter microstructure and treatment response of late-life depression: A preliminary study. Am J Psychiatry 159, 1929–32.
Bae J N , MacFall J R , Krishnan K R , Payne M E , Steffens D C and Taylor W D . 2006. Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. Biol Psychiatry 60, 1356–63.
Ballmaier M , Toga A W , Blanton R E , et al. 2004b. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 161, 99–108.
Barbosa S , Blumhardt L D , Roberts N , Lock T and Edwards R H . 1994. Magnetic resonance relaxation time mapping in multiple sclerosis: Normal appearing white matter and the “invisible” lesion load. Magn Reson Imaging 12, 33–42.
Ehrlich S , Noam G G , Lyoo I K , Kwon B J , Clark M A and Renshaw P F . 2004. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 43, 770–6.
Figiel G S , Krishnan K R , Doraiswamy P M , Rao V P , Nemeroff C B and Boyko O B . 1991. Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late age onset and early onset elderly depressed subjects. Neurobiol Aging 12, 245–7.
Frodl T , Meisenzahl E M , Zetzsche T , et al. 2004. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 65, 492–9.
Frodl T , Zill P , Baghai T , et al. 2008a. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. Am J Med Genet B Neuropsychiatr Genet 147B, 1003–07.
Greenwald B S , Kramer-Ginsberg E , Krishnan K R , Ashtari M , Auerbach C and Patel M . 1998. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 29, 613–7.
Greenwald B S , Kramer-Ginsberg E , Krishnan K R , et al. 2001. A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. J Am Geriatr Soc 49, 1218–25.
Hickie I , Scott E , Mitchell P , Wilhelm K , Austin M P and Bennett B . 1995. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37, 151–60.
Hickie I , Scott E , Wilhelm K and Brodaty H . 1997. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression – A longitudinal evaluation. Biol Psychiatry 42, 367–74.
Hickie I B , Naismith S L , Ward P B , et al. 2007. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord 98, 137–42.
Kumar A , Gupta R C , Albert T M , Alger J , Wyckoff N and Hwang S . 2004. Biophysical changes in normal-appearing white matter and subcortical nuclei in late-life major depression detected using magnetization transfer. Psychiatry Res 130, 131–40.
Kumar A , Mintz J , Bilker W and Gottlieb G . 2002. Autonomous neurobiological pathways to late-life major depressive disorder: Clinical and pathophysiological implications. Neuropsychopharmacology 26, 229–36.
Lampe I K , Hulshoff Pol H E , Janssen J , Schnack H G , Kahn R S and Heeren T J . 2003. Association of depression duration with reduction of global cerebral gray matter volume in female patients with recurrent major depressive disorder. Am J Psychiatry 160, 2052–4.
Lavretsky H , Ballmaier M , Pham D , Toga A and Kumar A . 2007. Neuroanatomical characteristics of geriatric apathy and depression: A magnetic resonance imaging study. Am J Geriatr Psychiatry 15, 386–94.
Matsuo K , Rosenberg D R , Easter P C , et al. 2008. Striatal volume abnormalities in treatment-naive patients diagnosed with pediatric major depressive disorder. J Child Adolesc Psychopharmacol 18, 121–31.
Murata T , Kimura H , Omori M , et al. 2001. MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: A comparison of early- and late-onset cases. Int J Geriatr Psychiatry 16, 1129–35.
Naismith S , Hickie I , Ward P B , et al. 2002. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. Am J Psychiatry 159, 2096–8.
Nobuhara K , Okugawa G , Sugimoto T , et al. 2006. Frontal white matter anisotropy and symptom severity of late-life depression: A magnetic resonance diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 77, 120–2.
O'Brien J , Ames D , Chiu E , Schweitzer I , Desmond P and Tress B . 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow up study. BMJ 317, 982–4.
O'Brien T J , Lloyd A , McKeith I , Gholkar A and Ferrier N . 2004. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161, 2081–90.
Pillay S S , Renshaw P F , Bonello C M , Lafer B C , Fava M and Yurgelun-Todd D . 1998. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Psychiatry Res 84, 61–74.
Pillay S S , Yurgelun-Todd D A , Bonello C M , Lafer B , Fava M and Renshaw P F . 1997. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Biol Psychiatry 42, 79–84.
Pompili M , Innamorati M , Mann J J , et al. 2008. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 32, 1501–07.
Salloway S , Boyle P A , Correia S , et al. 2002. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry 10, 107–11.
Sheline Y I , Price J L , Vaishnavi S N , et al. 2008. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry 165, 524–32.
Siegle G J , Konecky R O , Thase M E and Carter C S . 2003. Relationships between amygdala volume and activity during emotional information processing tasks in depressed and never-depressed individuals: An fMRI investigation. Ann N Y Acad Sci 985, 481–4.
Simpson S W , Baldwin R C , Burns A and Jackson A . 2001. Regional cerebral volume measurements in late-life depression: Relationship to clinical correlates, neuropsychological impairment and response to treatment. Int J Geriatr Psychiatry 16, 469–76.
Simpson S , Baldwin R C , Jackson A and Burns A S . 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 28, 1015–26.
Simpson S W , Jackson A , Baldwin R C and Burns A . 1997. 1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: Acute response to treatment and neuropsychological impairment. Int Psychogeriatr 9, 257–75.
Sonohara K , Kozaki K , Akishita M , et al. 2008. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly. Geriatr Gerontol Int 8, 93–100.
Steffens D C , Conway C R , Dombeck C B , Wagner H R , Tupler L A and Weiner R D . 2001. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT 17, 45–9.
Steffens D C , Potter G G , McQuoid D R , et al. 2007. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry 15, 839–49.
Steffens D C , Trost W T , Payne M E , Hybels C F and MacFall J R . 2003. Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. Biol Psychiatry 54, 674–81.
Taylor W D , MacFall J R , Steffens D C , Payne M E , Provenzale J M and Krishnan K R . 2003a. Localization of age-associated white matter hyperintensities in late-life depression. Prog Neuropsychopharmacol Biol Psychiatry 27, 539–44.
Taylor W D , Zuchner S , McQuoid D R , et al. 2008b. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry 16, 263–71.
Tupler L A , Krishnan K R , McDonald W M , Dombeck C B , D'Souza S and Steffens D C . 2002. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. J Psychosom Res 53, 665–76.
von Gunten A , Fox N C , Cipolotti L and Ron M A , 2000. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J Neuropsychiatry Clin Neurosci 12, 493–8.
Aizenstein H J , Butters M A , Figurski J L , Stenger V A , Reynolds C F , III and Carter C S. 2005. Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 58, 290–6.
Anand A , Li Y , Wang Y , Gardner K and Lowe M J. 2007. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: An fMRI study. J Neuropsychiatry Clin Neurosci 19, 274–82.
Ballmaier M , Toga A W , Blanton R E , et al. 2004. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 161, 99–108.
Barch D M , Sheline Y I , Csernansky J G and Snyder A Z. 2003. Working memory and prefrontal cortex dysfunction: Specificity to schizophrenia compared with major depression. Biol Psychiatry 53, 376–84.
Bhagwagar Z , Cowen P J , Goodwin G M and Harmer C J. 2004. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression. Am J Psychiatry 161, 166–8.
Bouhuys A L , Geerts E and Gordijn M C M. 1999. Depressed patients' perceptions of facial emotions in depressed and remitted states are associated with relapse: A longitudinal study. J Nerv Mental Dis 187, 595–602.
Brassen S , Kalisch R , Weber-Fahr W , Braus D F and Buchel C. 2008. Ventromedial prefrontal cortex processing during emotional evaluation in late-life depression: A longitudinal functional magnetic resonance imaging study. Biol Psychiatry 64, 349–55.
Brody A L , Saxena S , Stoessel P , et al. 2001. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Arch Gen Psychiatry 58, 631–40.
Drevets W C , Bogers W and Raichle M E. 2002. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12, 527–44.
Fu C H , Williams S C , Cleare A J , et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61, 877–89.
George M S , Ketter T A , Parekh P I , Rosinsky N , Ring H A and Pazzaglia P J. 1997. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci 9, 55–63.
Gonul A S , Kula M , Bilgin A G , Tutus A and Oguz A. 2004. The regional cerebral blood flow changes in major depressive disorder with and without psychotic features. Prog Neuropsychopharmacol Biol Psychiatry 28, 1015–21.
Greicius M D , Flores B H , Menon V , et al. 2007. Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 62, 429–37.
Gusnard D A , Akbudak E , Shulman G L and Raichle M E . 2001. Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function. Proc Natl Acad Sci U S A 98, 4259–64.
Hasler G , Fromm S , Carlson P J , et al. 2008. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65, 521–31.
Hickie I , Scott E , Mitchell P , Wilhelm K , Austin M P and Bennett B. 1995. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37, 151–60.
Keedwell P , Drapier D , Surguladze S , Giampietro V , Brammer M and Phillips M. 2009. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J Psychopharmacol 23, 775–88.
Keedwell P A , Andrew C , Williams S C , Brammer M J and Phillips M L. 2005a. A double dissociation of ventromedial prefrontal cortical responses to sad and happy stimuli in depressed and healthy individuals. Biol Psychiatry 58, 495–503.
Kennedy S H , Konarski J Z , Segal Z V , et al. 2007. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164, 778–88.
Lang P J , Bradley M M and Cuthbert B N. 2001. International Affective Picture System (IAPS): Instruction Manual and Affective Ratings. Technical Report A-5 The Center for Research in Psychophysiology, University of Florida.
Lawrence N S , Williams A M , Surguladze S A , et al. 2004. Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 55, 578–87.
Liotti M , Mayberg H S , McGinnis S , Brannan S L and Jerabek P. 2002. Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159, 1830–40.
Mannie Z N , Norbury R , Murphy S E , Inkster B , Harmer C J and Cowen P J. 2008. Affective modulation of anterior cingulate cortex in young people at increased familial risk of depression. Br J Psychiatry 192, 356–61.
Martin S D , Martin E , Rai S S , Richardson M A and Royall R. 2001. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Arch Gen Psychiatry 58, 641–8.
Mayberg H S , Liotti M , Brannan S K , McGinnis B S , Mahurin R K and Jerabek P A. 1999. Reciprocal limbic–cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 156, 675–82.
McKiernan K A , Kaufman J N , Kucera-Thompson J and Binder J R. 2003. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J Cognit Neurosci 15, 394–408.
Monchi O , Petrides M , Petre V , Worsley K and Dagher A. 2001. Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21, 7733–41.
Monk C S , Klein R G , Telzer E H , et al. 2008. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 165, 90–8.
Moreaud O , Naegele B , Chabannes J P , Roulin J L , Garbolino B and Pellat J. 1996. Frontal lobe dysfunction and depression: Relation with the endogenous nature of the depression. Encephale 22, 47–51.
Neumeister A , Nugent A C , Waldeck T , et al. 2004. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61, 765–73.
Perico C A M , Skaf C R , Yamada A , et al. 2005. Relationship between regional cerebral blood flow and separate symptom clusters of major depression: A single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett 384, 265–70.
Phillips M L , Ladouceur C D and Drevets W C. 2008. A neural model of voluntary and automatic emotion regulation: Implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 13, 833–57.
Sheline Y I , Barch D M , Donnelly J M , Ollinger J M , Snyder A Z and Mintun M A. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 50, 651–8.
Siegle G J , Steinhauer S R , Thase M E , Stenger V A and Carter C S. 2002. Can't shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 51, 693–707.
Siegle G J , Thompson W , Carter C S , Steinhauer S R and Thase M E. 2007. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: Related and independent features. Biol Psychiatry 61, 198–209.
Surguladze S A , Young A W , Senior C , Brebion G , Travis M J and Phillips M L. 2004. Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 18, 212–8.
Tremblay L K , Naranjo C A , Graham S J , et al. 2005. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62, 1228–36.
Walsh N D , Williams S C R , Brammer M J , et al. 2007. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry 62, 1236–43.
Yao Z , Wang L , Lu Q , Liu H and Teng G. 2008. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: A resting-state fMRI study. J Affect Disord 115, 430–8.
Zola-Morgan S , Squire L R , varez-Royo P and Clower R P. 1991. Independence of memory functions and emotional behavior: Separate contributions of the hippocampal formation and the amygdala. Hippocampus 1, 207–20.
Agren H , Reibring L , Hartvig P , et al. 1991. Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: A positron emission tomography study on patients and healthy volunteers. Acta Psychiatr Scand 83, 449–55.
Arango V , Underwood M D , Gubbi A V and Mann J J. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688, 121–33.
Bhagwagar Z , Hinz R , Taylor M , Fancy S , Cowen P and Grasby P. 2006. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100,907. Am J Psychiatry 163, 1580–7.
Bhagwagar Z , Murthy N , Selvaraj S , et al. 2007. 5-HTT binding in recovered depressed patients and healthy volunteers: A positron emission tomography study with [11C]DASB. Am J Psychiatry 164, 1858–65.
Blier P , de Montigny C and Chaput Y. 1990. A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence. J Clin Psychiatry 51 (Suppl), 14–20; discussion 21.
Blin J , Sette G , Fiorelli M , et al. 1990. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. J Neurochem 54, 1744–54.
Brücke T , Kornhuber J , Angelberger P , Asenbaum S , Frassine H , and Podreka I . 1993. SPECT imaging of dopamine and serotosin transporters with [123I]beta-CIT. Binding kinetics in the human brain. J Neurol Transm Gen Sect 94, 137–46.
Cannon D M , Ichise M , Rollis D , et al. 2007. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biol Psychiatry 62, 870–7.
Cannon D M , Klaver J M , Peck S A , Rallis-Voak D , Erickson K and Drevets W C. 2009. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology, 5, 1277–87.
Carson R E , Kiesewetter D O , Jagoda E , Der M G , Herscovitch P and Eckelman W C. 1998. Muscarinic cholinergic receptor measurements with [18F]FP-TZTP: Control and competition studies. J Cereb Blood Flow Metab 18, 1130–42.
Catafau A M , Perez V , Plaza P , et al. 2006. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: A 123I-ADAM SPECT study. Psychopharmacology (Berl) 189, 145–53.
Chaly T , Dhawan V , Kazumata K , et al. 1996. Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol 23, 999–1004.
Conwell Y , Duberstein P R , Cox C , Herrmann J H , Forbes N T and Caine E D. 1996. Relationships of age and axis I diagnoses in victims of completed suicide: A psychological autopsy study. Am J Psychiatry 153, 1001–08.
Cortes R , Soriano E , Pazos A , Probst A and Palacios J M. 1988. Autoradiography of antidepressant binding sites in the human brain: Localization using [3H]imipramine and [3H]paroxetine. Neuroscience 27, 473–96.
DaSilva J N , Lourenco C M , Meyer J H , Hussey D , Potter W Z and Houle S. 2002. Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[(11)C]rolipram and positron emission tomography. Eur J Nucl Med Mol Imag 29, 1680–3.
Dewey S L , Smith G , Logan J , Brodie J D , Fowler J S and Wolf A P. 1993. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13, 350–6.
Ebert D , Feistel H , Kaschka W , Barocka A and Pirner A. 1994. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation – Preliminary results. Biol Psychiatry 35, 880–5.
Farde L , Ehrin E , Eriksson L , et al. 1985. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc Natl Acad Sci USA 82, 3863–7.
Ferrarese C , Guidotti A , Costa E , et al. 1991. In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine, a possible ligand for positron emission tomography. Neuropharmacology 30, 899–905.
Francis P T , Pangalos M N , Stephens P H , et al. 1993. Antemortem measurements of neurotransmission: Possible implications for pharmacotherapy of Alzheimer's disease and depression. J Neurol Neurosurg Psychiatry 56, 80–4.
Frankle W G , Lombardo I , New A S , et al. 2005. Brain serotonin transporter distribution in subjects with impulsive aggressivity: A positron emission study with [11C]McN 5652. Am J Psychiatry 162, 915–23.
Frokjaer V G , Mortensen E L , Nielsen F A , et al. 2008. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 63, 569–76.
Frost J J , Rosier A J , Reich S G , et al. 1993. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann Neurol 34, 423–31.
Fujita M , Imaizumi M , Zoghbi S S , et al. 2008. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 40, 43–52.
George T P , Sacco K A , Vessicchio J C , Weinberger A H and Shytle R D. 2008. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: A preliminary study. J Clin Psychopharmacol 28, 340–4.
Ginovart N , Wilson A A , Meyer J H , Hussey D and Houle S. 2001. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: Modeling strategies. J Cereb Blood Flow Metab 21, 1342–53.
Giovacchini G , Chang M C , Channing M A , et al. 2002. Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab 22, 1453–62.
Hirvonen J , Aalto S , Hagelberg N , et al. 2009. Measurement of central micro-opioid receptor binding in vivo with PET and [(11)C]carfentanil: A test–retest study in healthy subjects. Eur J Nucl Med Mol Imaging 36, 275–86.
Hirvonen J , Karlsson H , Kajander J , et al. 2008. Striatal dopamine D2 receptors in medication-naïve patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) 197, 581–90.
Houle S , Ginovart N , Hussey D , Meyer J H and Wilson A A. 2000. Imaging the serotonin transporter with positron emission tomography: Initial human studies with [11C]DAPP and [11C]DASB. Eur J Nucl Med 27, 1719–22.
Hoyer D , Pazos A , Probst A and Palacios J M. 1986a. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376, 85–96.
Hoyer D , Pazos A , Probst A and Palacios J M. 1986b. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376, 97–107.
Kessler R C , Chiu W T , Demler O , Merikangas K R and Walters E E. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62, 617–27.
Klein N , Sacher J , Geiss-Granadia T , et al. 2006. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. Psychopharmacology (Berl) 188, 263–72.
Klein N , Sacher J , Geiss-Granadia T , et al. 2007. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: An [123I]ADAM SPECT study. Psychopharmacology (Berl) 191, 333–9.
Klimke A , Larisch R , Janz A , Vosberg H , Muller-Gartner H W and Gaebel W. 1999. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90, 91–101.
Koeppe R A , Frey K A , Snyder S E , Meyer P , Kilbourn M R and Kuhl D E. 1999. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab 19, 1150–63.
Koeppe R A , Holthoff V A , Frey K A , Kilbourn M R and Kuhl D E. 1991. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 11, 735–44.
Kugaya A , Seneca N M , Snyder P J , et al. 2003. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28, 413–20.
Kung M P , Hou C , Oya S , Mu M , Acton P D and Kung H F. 1999. Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters. Eur J Nucl Med 26, 844–53.
Leopoldo M , Berardi F , Colabufo N A , et al. 2002. Structure–affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands. J Med Chem 45, 5727–35.
Lopez J F , Chalmers D T , Little K Y and Watson S J. 1998. A.E. Bennett research award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol Psychiatry 43, 547–73.
Malison R T , Price L H , Berman R , et al. 1998. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44, 1090–8.
Mann J J , Huang Y Y , Underwood M D , et al. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57, 729–38.
Massou J M , Trichard C , Attar-Levy D , et al. 1997. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133, 99–101.
Mathis C A , Wang Y , Holt D P , Huang G F , Debnath M L and Klunk W E. 2003. Synthesis and evaluation of (11)C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46, 2740–54.
Mengod G , Pompeiano M , Martínez-Mir M I and Palacios J M. 1990. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524, 139–43.
Messa C , Colombo C , Moresco R M , et al. 2003. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: A PET study. Psychopharmacology 167, 72–8.
Meyer J H , Cho R , Kennedy S and Kapur S. 1999a. The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET. Psychopharmacology 144, 279–81.
Meyer J H , Houle S , Sagrati S , et al. 2004. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61, 1271–9.
Meyer J H , Wilson A A , Ginovart N , et al. 2001b. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [(11)C]DASB PET imaging study. Am J Psychiatry 158, 1843–9.
Miller J M , Oquendo M A , Ogden R T , Mann J J and Parsey R V. 2008. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatric Res 42, 1137–44.
Mukherjee J , Christian B T , Dunigan K A , et al. 2002. Brain imaging of 18F-fallypride in normal volunteers: Blood analysis, distribution, test–retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46, 170–88.
Muller-Gartner H W , Wilson A A , Dannals R F , Wagner H N Jr and Frost J J. 1992. Imaging muscarinic cholinergic receptors in human brain in vivo with Spect, [123I]4-iododexetimide, and [123I]4-iodolevetimide. J Cereb Blood Flow Metab 12, 562–70.
Mullins D , Adham N , Hesk D , et al. 2008. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y(5) receptor and development of a novel Y(5)-selective radioligand. Eur J Pharmacol 601, 1–7.
Murray C. 1996. Rethinking DALYs. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health.
Nomura M and Nomura Y. 2006. Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans. Ann N Y Acad Sci 1086, 134–43.
Nordberg A , Lundqvist H , Hartvig P , Lilja A and Langstrom B. 1995. Kinetic analysis of regional (S) (–)11C-nicotine binding in normal and Alzheimer brains – in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9, 21–7.
Okazawa H , Leyton M , Benkelfat C , Mzengeza S and Diksic M. 2000. Statistical mapping analysis of serotonin synthesis images generated in healthy volunteers using positron-emission tomography and alpha-[11C]methyl-L-tryptophan. J Psychiatry Neurosci 5, 359–70.
Oquendo M A , Hastings R S , Huang Y Y , et al. 2007. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry 64, 201–08.
Parsey R V , Oquendo M A , Simpson N R , et al. 2002. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954, 173–82.
Pierson M E , Andersson J , Nyberg S , et al. 2008. [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage 41, 1075–85.
Pifferi F , Tremblay S , Plourde M , Tremblay-Mercier J , Bentourkia M and Cunnane S C. 2008. Ketones and brain function: Possible link to polyunsaturated fatty acids and availability of a new brain PET tracer, 11C-acetoacetate. Epilepsia 49 (Suppl 8), 76–9.
Reimold M , Batra A , Knobel A , et al. 2008. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: A [11C]DASB PET study. Mol Psychiatry 13, 606–13, 557.
Rosa-Neto P , Diksic M , Okazawa H , et al. 2004. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry 61, 556–63.
Rousset O G , Collins D L , Rahmim A and Wong D F. 2008. Design and implementation of an automated partial volume correction in PET: Application to dopamine receptor quantification in the normal human striatum. J Nucl Med 49, 1097–106.
Sargent P A , Kjaer K H , Bench C J , et al. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57, 174–80.
Satyamurthy N , Barrio J R , Bida G T , Huang S C , Mazziotta J C and Phelps M E. 1990. 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Int J Radiat App Instrument – Part A, Appl Radiat Isotopes 41, 113–29.
Sen S , Nesse R M , Stoltenberg S F , et al. 2003. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397–401.
Shioe K , Ichimiya T , Suhara T , et al. 2003. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48, 184–8.
Shoghi-Jadid K , Small G W , Agdeppa E D , et al. 2002. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriat Psychiatry 10, 24–35.
Smith G , Price J C , Lopresti B J , et al. 1998. Test–retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain. Synapse 30, 380–92.
Smith G S , Gunning-Dixon F M , Lotrich F E , Taylor W D and Evans J D. 2007. Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology 32, 1857–75.
Smith G S , Ma Y , Dhawan V , Chaly T and Eidelberg D. 2009. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse 63, 1–6.
Smith J S , Zubieta J K , Price J C , et al. 1999. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography. J Cereb Blood Flow Metab 19, 956–66.
Sorger D , Scheunemann M , Grossmann U , et al. 2008. A new 18F-labeled fluoroacetylmorpholino derivative of vesamicol for neuroimaging of the vesicular acetylcholine transporter. Nucl Med Biol 35, 185–95.
Sotelo C , Cholley B , El Mestikawy S , Gozlan H and Hamon M. 1990. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2, 1144–54.
Staley J K , van Dyck C H , Weinzimmer D , et al. 2005. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: Feasibility and reproducibility. J Nucl Med 46, 1466–72.
Steiniger B , Kniess T , Bergmann R , Pietzsch J and Wuest F R. 2008. Radiolabeled glucocorticoids as molecular probes for imaging brain glucocorticoid receptors by means of positron emission tomography (PET). Mini Rev Med Chem 8, 728–39.
Stephenson K A , van Oosten E M , Wilson A A , Meyer J H , Houle S and Vasdev N. 2008. Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-exaprolol for imaging cerebral beta-adrenergic receptors with PET. Neurochem Int 53, 173–9.
Stockmeier C A , Shapiro L A , Haycock J W , Thompson P A and Lowy M T. 1996. Quantitative subregional distribution of serotonin1A receptors and serotonin transporters in the human dorsal raphe. Brain Res 727, 1–12.
Strome E M , Clark C M , Zis A P and Doudet D J. 2005. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: An in vivo positron emission tomography study with [18F]setoperone. Biol Psychiatry 57, 1004–10.
Syvanen S , Eriksson J , Genchel T , Lindhe O , Antoni G and Langstrom B. 2007. Synthesis of two potential NK1-receptor ligands using [1–11C]ethyl iodide and [1–11C]propyl iodide and initial PET-imaging. BMC Med Imaging 7, 6.
Takano A , Gulyas B , Varrone A , et al. 2008. Imaging the norepinephrine transporter with positron emission tomography: Initial human studies with (S,S)-[(18)F]FMeNER-D (2). Eur J Nucl Med Mol Imaging 35, 153–7.
Tauscher J , Bagby R M , Javanmard M , Christensen B K , Kasper S and Kapur S. 2001. Inverse relationship between serotonin 5-HT(1A) receptor binding and anxiety: A [(11)C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 158, 1326–8.
Tweedie D J and Burke M D. 1987. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites. Drug Metab Disposition: Biol Fate Chem 15, 74–81.
Vasdev N , LaRonde F J , Woodgett J R , et al. 2008. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide. Bioorg Med Chem 16, 5277–84.
Willeit M , Stastny J , Pirker W , et al. 2001. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 50, 8–12.
Wilson A A , Ginovart N , Hussey D , Meyer J and Houle S. 2002. In vitro and in vivo characterisation of [11C]-DASB: A probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nucl Med Biol 29, 509–15.
Yasuno F , Ota M , Kosaka J , et al. 2008. Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry 64, 835–41.
Yasuno F , Sanabria S M , Burns D , et al. 2007. PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: Assessment of reference tissue models and their test–retest reproducibility. Synapse 61, 242–51.
Yatham L N , Liddle P F , Dennie J , et al. 1999. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry 56, 705–11.
Yatham L N , Liddle P F , Lam R W , et al. 2002b. PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 159, 1718–23.
Yatham L N , Liddle P F , Shiah I S , et al. 2002a. PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: Effects of treatment with divalproex sodium. Am J Psychiatry 159, 768–74.
Yu Y W , Tsai S J , Chen T J , Lin C H and Hong C J. 2002. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7, 1115–9.
Zoghbi S S , Baldwin R M , Seibyl J P , et al. 1992. Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates. Int J Radiat Applic Instrum – Part B, Nucl Med Biol 19, 881–8.
Zubieta J K , Taylor S F , Huguelet P , Koeppe R A , Kilbourn M R and Frey K A. 2001b. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry 49, 110–6.
Abe O , Yamasue H , Kasai K , et al. 2006. Voxel-based diffusion tensor analysis reveals aberrant anterior cingulum integrity in posttraumatic stress disorder due to terrorism. Psychiatry Res Neuroimag 146, 231–42.
Araki T , Kasai K , Yamasue H , et al. 2005. Association between lower P300 amplitude and smaller anterior cingulated cortex volume in patients with posttraumatic stress disorder: a study of victims of Tokyo subway sarin attack. NeuroImage 25, 43–50.
Bossini L , Tavanti M , Calossi S , et al. 2008. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatric Res 42, 752–62.
Bremner J D , Randall P , Vermetten E , et al. 1997. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse – A preliminary report. Biol Psychiatry 41, 23–32.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 160, 924–32.
Carrion V G , Weems C F and Reiss A L. 2007. Stress predicts brain changes in children: A pilot longitudinal study on youth stress, posttraumatic stress disorder, and the hippocampus. Pediatrics 119, 509–16.
Chen S , Xia W , Li L , et al. 2006. Gray matter density reduction in the insula in fire survivors with posttraumatic stress disorder: A voxel-based morphometric study. Psychiatry Res Neuroimag 146, 65–72.
Corbo V , Clément M H , Armony J L , et al. 2005. Size versus shape differences: Contrasting voxel-based and volumetric analyses of the anterior cingulate cortex in individuals with acute posttraumatic stress disorder. Biol Psychiatry 58, 119–24.
De Bellis M D , Keshavan M S , Shifflett H , et al. 2002a. Brain structures in pediatric maltreatment-related posttraumatic stress disorder: A sociodemographically matched study. Biol Psychiatry 52, 1066–78.
Emdad R , Bonekamp D , Sondergaard H P , et al. 2006. Morphometric and psychometric comparisons between non-substance-abusing patients with posttraumatic stress disorder and normal controls. Psychother Psychosom 75, 122–32.
Fennema-Notestine C , Stein M B , Kennedy C M , et al. 2002. Brain morphometry in female victims of intimate partner violence with and without posttraumatic stress disorder. Biol Psychiatry 51, 1089–101.
Freeman T W , Cardwell D , Karson C N and Komoroski R A. 1998. In vivo proton magnetic resonance spectroscopy of the medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Reson Med 40, 66–71.
Golier J A , Yehuda R , DeSanti S , et al. 2005. Absence of hippocampal volume differences in survivors of the Nazi Holocaust with and without posttraumatic stress disorder. Psychiatry Res Neuroimag 139, 53–64.
Ham B J , Chey J , Yoon S J , et al. 2007. Decreased N-acetyl-aspartate levels in anterior cingulate and hippocampus in subjects with post-traumatic stress disorder: A proton magnetic resonance spectroscopy study. Eur J Neurosci 25, 324–9.
Jackowski A P , Douglas-Palumberi H , Jackowski M , et al. 2008. Corpus callosum in maltreated children with posttraumatic stress disorder: A diffusion tensor imaging study. Psychiatry Res Neuroimag 162, 256–61.
Kasai K , Yamasue H , Gilbertson M W , et al. 2008. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol Psychiatry 63, 550–6.
Letizia B , Maricla T , Sara C , et al. 2008. Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions. J Psychiatric Res 42, 752–62.
Levitt J J , Chen Q C , May F S , et al. 2006. Volume of cerebellar vermis in monozygotic twins discordant for combat exposure: Lack of relationship to posttraumatic stress disorder. Psychiatry Res Neuroimag 148, 143–9.
Li L , Chen S , Liu J , et al. 2006. Magnetic resonance imaging and magnetic resonance spectroscopy study of deficits in hippocampal structure in fire victims with recent-onset posttraumatic stress disorder. Can J Psychiatry 51, 431–7.
Mahmutyazicioğlu K , Konuk N , Ozdemir H , et al. 2005. Evaluation of the hippocampus and the anterior cingulate gyrus by proton MR spectroscopy in patients with post-traumatic stress disorder. Diagn Interven Radiol 11, 125–9.
Margarinos A M , McEwen B S , Flugge G and Fuchs E. 1996. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 16, 3534–40.
May F S , Chen Q C , Gilbertson M W , et al. 2004. Cavum septum pellucidum in monozygotic twins discordant for combat exposure: Relationship to posttraumatic stress disorder. Biol Psychiatry 55, 656–8.
Pederson C L , Maurer S H , Kaminski P L , et al. 2004. Hippocampal volume and memory performance in a community-based sample of women with posttraumatic stress disorder secondary to child abuse. J Traumat Stress 17, 37–40.
Schwegler H and Lipp H P. 1983. Hereditary covariations of neuronal circuitry and behavior: Correlations between the proportions of hippocampal synaptic fields in the regio inferior and two-way avoidance in mice and rats. Behav Brain Res 7, 1–38.
Smith M A , Makino S , Kvetnansky R and Post R M. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotorphin-3 mRNAs in the hippocampus. J Neurosci 15, 1768–77.
Villarreal G , Petropoulos H , Hamilton D A , et al. 2002b. Proton magnetic resonance spectroscopy of the hippocampus and occipital white matter in PTSD: Preliminary results. Can J Psychiatry 47, 666–70.
Yamasue H , Kasai K , Iwanami A , et al. 2003. Voxel-based analysis of MRI reveals anterior cingulate gray-matter volume reduction in posttraumatic stress disorder due to terrorism. Proc Natl Acad Sci 100, 9039–43.
Yehuda R , Golier J A , Tischler L , et al. 2007. Hippocampal volume in aging combat veterans with and without post-traumatic stress disorder: Relation to risk and resilience factors. J Psychiatric Res 41, 435–45.
Bremner J D , Innis R B , Ng C K , et al. 1997. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 54, 246–54.
Bremner J D , Narayan M , Staib L H , Southwick S M , McGlashan T and Charney D S. 1999a. Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry 156, 1787–95.
Bremner J D , Staib L H , Kaloupek D , Southwick S M , Soufer R and Charney D S. 1999b. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: A positron emission tomography study. Biol Psychiatry 45, 806–16.
Bremner J D , Vermetten E , Schmahl C , et al. 2005. Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychol Med 35, 791–806.
Bremner J D , Vermetten E , Vythilingam M , et al. 2004 Neural correlates of the classic color and emotional stroop in women with abuse-related posttraumatic stress disorder. Biol Psychiatry 55, 612–20.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003a. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 160, 924–32.
Bremner J D , Vythilingam M , Vermetten E , et al. 2003b. Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry 53, 879–89.
Bryant R A , Felmingham K L , Kemp A H , et al. 2005. Neural networks of information processing in posttraumatic stress disorder: A functional magnetic resonance imaging study. Biol Psychiatry 58, 111–8.
Bryant R A , Felmingham K , Kemp A , Das P , Hughes G , Peduto A and Williams L. 2008a. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med 38, 555–61.
Bryant R A , Kemp A H , Felmingham K L , et al. 2008b. Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: An fMRI study. Hum Brain Mapp 29, 517–23.
Carrion V G , Garrett A , Menon V , Weems C F and Reiss A L. 2008. Posttraumatic stress symptoms and brain function during a response-inhibition task: An fMRI study in youth. Depress Anxiety 25, 514–26.
Chung Y A , Kim S H , Chung S K , et al. 2006. Alterations in cerebral perfusion in posttraumatic stress disorder patients without re-exposure to accident-related stimuli. Clin Neurophysiol 117, 637–42.
Driessen M , Beblo T , Mertens M , et al. 2004. Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder. Biol Psychiatry 55, 603–11.
Fernandez M , Pissiota A , Frans O , von Knorring L , Fischer H and Fredrikson M. 2001. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: A positron emission tomography provocation study. Neurosci Lett 297, 101–04.
Frewen P , Lane R D , Neufeld R W , Densmore M , Stevens T and Lanius R. 2008. Neural correlates of levels of emotional awareness during trauma script-imagery in posttraumatic stress disorder. Psychosom Med 70, 27–31.
Hopper J W , Frewen P A , van der Kolk B A and Lanius R A. 2007. Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: Symptom dimensions and emotion dysregulation in responses to script-driven trauma imagery. J Trauma Stress 20, 713–25.
Hou C , Liu J , Wang K , et al. 2007. Brain responses to symptom provocation and trauma-related short-term memory recall in coal mining accident survivors with acute severe PTSD. Brain Res 1144, 165–74.
Lanius R , Williamson P , Boksman K , et al. 2002. Brain activation during script-driven imagery induced dissociative responses in PTSD: A functional magnetic resonance imaging investigation. Biol Psychiatry 52, 305.
Lanius R A , Williamson P C , Bluhm R L , et al. 2005. Functional connectivity of dissociative responses in posttraumatic stress disorder: A functional magnetic resonance imaging investigation. Biol Psychiatry 57, 873–84.
Lansing K , Amen D G , Hanks C and Rudy L. 2005. High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD. J Neuropsychiatry Clin Neurosci 17, 526–32.
Levin P , Lazrove S. and van der Kolk B. 1999. What psychological testing and neuroimaging tell us about the treatment of Posttraumatic Stress Disorder by Eye Movement Desensitization and Reprocessing. J Anxiety Disord 13, 159–72.
Moores K A , Clark C R , McFarlane A C , Brown G C , Puce A and Taylor D J. 2008. Abnormal recruitment of working memory updating networks during maintenance of trauma-neutral information in post-traumatic stress disorder. Psychiatry Res 163, 156–70.
Morey R A , Dolcos F , Petty C M , et al. 2008. The role of trauma-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. J Psychiatr Res 43, 809–17.
Osuch E A , Willis M W , Bluhm R , Ursano R J and Drevets W C. 2008. Neurophysiological responses to traumatic reminders in the acute aftermath of serious motor vehicle collisions using [15O]-H2O positron emission tomography. Biol Psychiatry 64, 327–35.
Pavic L , Gregurek R , Petrovic R , et al. 2003. Alterations in brain activation in posttraumatic stress disorder patients with severe hyperarousal symptoms and impulsive aggressiveness. Eur Arch Psychiatry Clin Neurosci 253, 80–3.
Pissiota A , Frans O , Fernandez M , von Knorring L , Fischer H and Fredrikson M. 2002. Neurofunctional correlates of posttraumatic stress disorder: A PET symptom provocation study. Eur Arch Psychiatry Clin Neurosci 252, 68–75.
Protopopescu X , Pan H , Tuescher O , et al. 2005. Differential time courses and specificity of amygdala activity in posttraumatic stress disorder subjects and normal control subjects. Biol Psychiatry 57, 464–73.
Rauch S L , van der Kolk B A , Fisler R E , et al. 1996. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 53, 380–7.
Sachinvala N , Kling A , Suffin S , Lake R and Cohen M. 2000. Increased regional cerebral perfusion by 99mTc hexamethyl propylene amine oxime single photon emission computed tomography in post-traumatic stress disorder. Mil Med 165, 473–9.
Sailer U , Robinson S , Fischmeister F P , et al. 2008. Altered reward processing in the nucleus accumbens and mesial prefrontal cortex of patients with posttraumatic stress disorder. Neuropsychologia 46, 2836–44.
Seedat S , Warwick J , van Heerden B , et al. 2004. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor. J Affect Disord 80, 45–53.